Fact CheckerSign in

NCT06074731Recruiting

Diagnostic Possibilities in Ophthalmological Diseases Using Swept Source Optical Coherence Tomography

Source: ClinicalTrials.gov · Last updated 10 Oct 2023 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

In this pilot study we want to investigate morphological features acquired by the novel image modality and gain information regarding disease pathomechanism, development and future possible influence on disease management for patients affected by those diseases.

Status (registry)
Recruiting
Study type
Observational
Enrollment
500 (estimated)
First submitted
15 Jan 2019
Start date
1 Jun 2017
Primary completion date
Dec 2025
Lead sponsor
Johannes Kepler University of Linz
NCT number
NCT06074731

What you commit to

  • Study type: Observational
  • Planned participants: 500
  • From 1 Jun 2017 to the primary completion date, Dec 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Dementia

Other

  • Inability to follow instructions during imaging procedure
  • Patients who do not give informed consent

Who the study is looking for

  • Age between 5 and 110 years
  • Ability to follow instructions during imaging procedure
  • Written Informed consent

Age in the registry: 5 years to 110 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Department for Ophthalmology and Optometry, Kepler University Hospital GmbH, Johannes Kepler University Linz, Altenberger Strasse 69, 4040 Linz, Austria
Coordinator of this site? Confirm its status
LinzAustriaRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.